- Home
- FA vs PRCT Comparison
FA vs PRCT Comparison
Compare FA & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FA
- PRCT
- Stock Information
- Founded
- FA 2003
- PRCT 2009
- Country
- FA United States
- PRCT United States
- Employees
- FA 10000
- PRCT N/A
- Industry
- FA Business Services
- PRCT Medical Specialities
- Sector
- FA Consumer Discretionary
- PRCT Health Care
- Exchange
- FA Nasdaq
- PRCT Nasdaq
- Market Cap
- FA 2.2B
- PRCT 2.0B
- IPO Year
- FA 2021
- PRCT 2021
- Fundamental
- Price
- FA $14.14
- PRCT $32.16
- Analyst Decision
- FA Buy
- PRCT Buy
- Analyst Count
- FA 4
- PRCT 9
- Target Price
- FA $20.67
- PRCT $63.50
- AVG Volume (30 Days)
- FA 784.0K
- PRCT 1.4M
- Earning Date
- FA 11-06-2025
- PRCT 11-04-2025
- Dividend Yield
- FA N/A
- PRCT N/A
- EPS Growth
- FA N/A
- PRCT N/A
- EPS
- FA N/A
- PRCT N/A
- Revenue
- FA $1,251,464,000.00
- PRCT $299,907,000.00
- Revenue This Year
- FA $84.14
- PRCT $48.38
- Revenue Next Year
- FA $5.93
- PRCT $30.87
- P/E Ratio
- FA N/A
- PRCT N/A
- Revenue Growth
- FA 65.34
- PRCT 50.07
- 52 Week Low
- FA $12.25
- PRCT $31.14
- 52 Week High
- FA $20.79
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- FA 49.60
- PRCT 37.77
- Support Level
- FA $12.25
- PRCT $33.38
- Resistance Level
- FA $14.75
- PRCT $35.71
- Average True Range (ATR)
- FA 0.55
- PRCT 1.76
- MACD
- FA -0.01
- PRCT -0.13
- Stochastic Oscillator
- FA 70.40
- PRCT 20.06
About FA First Advantage Corporation
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.